Tendinitis General
Of the 10 unique stories with a clear outcome, 10 reported it helped (100%). 1 duplicate retellings excluded.
These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.
“bicep tendonitis has really resided”
“I had a tendonitis in my elbow, started using BPC 157, it was gone in two weeks”
“Joe Rogan's elbow tendonitis was cured in two weeks”
“comparatively like two months or so without any use, this time three and a half weeks”
“my knees, they're sore... it's helping me massively”
“it's been feeling a lot better”
“my triceps have never felt better”
“pain was gone after two and a half weeks”
“I have mine for my tendon regrowth and healing”
“complete resolution of chronic tendon irritation”
Related research
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review.
This review concludes that BPC 157, a stable gastric pentadecapeptide, shows promise in treating complex musculoskeletal and junctional injuries, with efficacy in tendon, ligament, and muscle healing. BPC 157 appears to have a full cytoprotection range and can be administered systemically or locally without a carrier.
Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats.
This study found that BPC-157 therapy promotes healing and functional recovery of disabled myotendinous junctions in rats, counteracting muscle atrophy and oxidative stress. The treatment led to complete disappearance of defects and restoration of normal muscle presentation in treated rats.
Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing.
BPC 157 was found to modulate angiogenesis in muscle and tendon healing by up-regulating VEGF expression, leading to more adequate healing. This effect was observed in animal models of crushed and transected muscle and tendon.
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.
BPC-157, a synthetic peptide, has shown promise in preclinical models for tissue repair and pain management, with potential therapeutic value for various conditions, but human research is limited and more rigorous trials are needed. The review concludes that BPC-157 is a promising candidate for regenerative medicine, but comprehensive evaluation is required before clinical translation can be recommended.